| Model Number |
FG11815 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Codes |
Confusion/ Disorientation (2553); Unspecified Tissue Injury (4559)
|
| Date of Event |
04/23/2026
|
|
Type of Reportable Event
|
Death
|
|
Additional Manufacturer Narrative
|
|
H6.Patient codes: e2015 insufficient information is used as the cause of death is unknown.
|
| |
|
Event or Problem Description
|
|
It was reported that the patient died three days after the procedure.An enroute transcarotid stent was selected for use in the left transcarotid artery revascularization (tcar) procedure.Post procedure, the patient was slow to wake up which was attributed to age and the patient was sent to post-anesthesia care unit (pacu).Three days after the procedure, it was reported that the patient had passed away.Additionally, it was also reported that the patient had chronic kidney disease (ckd) and chronic obstructive pulmonary disease (copd).At this time, the patient's cause of death is unknown, and further information is not available.
|
| |
|
Event or Problem Description
|
|
It was reported that the patient died three days after the procedure.An enroute transcarotid stent was selected for use in the left transcarotid artery revascularization (tcar) procedure.Post procedure, the patient was slow to wake up which was attributed to age and the patient was sent to post-anesthesia care unit (pacu).Three days after the procedure, it was reported that the patient had passed away.Additionally, it was also reported that the patient had chronic kidney disease (ckd) and chronic obstructive pulmonary disease (copd).At this time, the patient's cause of death is unknown, and further information is not available.
|
| |
|
Additional Manufacturer Narrative
|
|
Investigation results:
a review of the manufacturing documentation associated with this lot was performed, and it was found that one defective unit was rejected during the final assembly of this lot.It was confirmed that the unit was properly segregated and discarded.No manufacturing deviations were identified that could be related to the reported complaint.The review did not suggest that the adverse event experienced by the customer could be related to the manufacturing process.Review of the instructions for use (ifu) confirmed that the content was sufficient and did not contribute to the reported event; therefore, no updates are required to the document at this time.A risk review performed for the enroute transcarotid stent device confirmed that the events does not represent a new or unanticipated risk.These event types were accounted for during the product risk analysis to support an acceptable risk benefit for the product.Based on a thorough review of the reported complaint the most probable cause for this complaint was considered no problem detected.----------------------------------------------------------------------------------
h6.Patient codes: e2015 insufficient information is used as the cause of death is unknown.
|
| |
|
Search Alerts/Recalls
|